Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balazs

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Immunity|February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized miceNicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Geroscience|October 12, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Cell Reports|April 2, 2025
Two distinct durable human class-switched memory B cell populations are induced by vaccination and infectionCory A Perugino, Hang Liu, Jared Feldman, et al.
Cell Reports|April 14, 2022
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infectionDevin J Kenney, Aoife K O'Connell, Jacquelyn Turcinovic, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort StudyVivek Naranbhai, Claire A Pernat, Alexander Gavralidis, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Immunity|February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized miceNicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Geroscience|October 12, 2024
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residentsYasin Abul, Clare Nugent, Igor Vishnepolskiy, et al.
Cell Reports|April 2, 2025
Two distinct durable human class-switched memory B cell populations are induced by vaccination and infectionCory A Perugino, Hang Liu, Jared Feldman, et al.
Cell Reports|April 14, 2022
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infectionDevin J Kenney, Aoife K O'Connell, Jacquelyn Turcinovic, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort StudyVivek Naranbhai, Claire A Pernat, Alexander Gavralidis, et al.
Pageof 11